Want to join the conversation?
Biotechnology company $AMGN said that a favorable verdict was delivered to the company by a Delaware jury in a trial on the validity of two $AMGN patents, Sanofi and $REGN. These patents describe and claim monoclonal antibodies to proprotein convertase subtilisin/kexin type 9 (PCSK9).
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.